Infectious Diseases

Merck’s molnupiravir is a twice-daily oral antiviral agent currently under study as a potential treatment for mild/moderate COVID-19.

Skin conditions may be directly related to COVID-19, or indirectly related due to use of personal protective equipment and frequent sanitization.

With schools reopening soon, Canadian parents are worried infections among children will soar.

While rules around mixed dosing are slowly being made more consistent, healthcare professionals should continue to reassure patients that they did the right thing by becoming fully-vaccinated.

A short text reminder may be all it takes to get patients to book their COVID-19 vaccines, show results of a large study.

Pharmacists can help clear confusion for patients who travel

As Canada looks to maximize the rollout of its COVID-19 vaccination program, Moderna is here to deliver second doses and provide support resources for pharmacists and other healthcare professionals.

Pharmacies in an ideal position to inform and encourage